Kura Oncology, Inc. (KURA)
KURA Stock Price Chart
Explore Kura Oncology, Inc. interactive price chart. Choose custom timeframes to analyze KURA price movements and trends.
KURA Company Profile
Discover essential business fundamentals and corporate details for Kura Oncology, Inc. (KURA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Sept 2015
Employees
192.00
Website
https://kuraoncology.comCEO
Troy Edward Wilson
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
KURA Financial Timeline
Browse a chronological timeline of Kura Oncology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.60, while revenue estimate is $17.48M.
Earnings released on 7 Aug 2025
EPS came in at -$0.75 falling short of the estimated $0.15 by -600.00%, while revenue for the quarter reached $15.29M , missing expectations by -76.46%.
Earnings released on 1 May 2025
EPS came in at -$0.66 falling short of the estimated -$0.51 by -29.41%, while revenue for the quarter reached $14.11M , missing expectations by -78.84%.
Earnings released on 26 Feb 2025
EPS came in at -$0.22 surpassing the estimated -$0.65 by +66.15%, while revenue for the quarter reached $53.88M , missing expectations by -7.04%.
Earnings released on 7 Nov 2024
EPS came in at -$0.63 surpassing the estimated -$0.64 by +1.56%.
Earnings released on 8 Aug 2024
EPS came in at -$0.59 surpassing the estimated -$0.63 by +6.35%.
Earnings released on 2 May 2024
EPS came in at -$0.59 falling short of the estimated -$0.56 by -5.36%.
Earnings released on 27 Feb 2024
EPS came in at -$0.55 surpassing the estimated -$0.56 by +1.79%, while revenue for the quarter reached $1.27M .
Earnings released on 2 Nov 2023
EPS came in at -$0.50 surpassing the estimated -$0.56 by +10.71%.
Earnings released on 3 Aug 2023
EPS came in at -$0.53 surpassing the estimated -$0.57 by +7.02%.
Earnings released on 10 May 2023
EPS came in at -$0.50 surpassing the estimated -$0.54 by +7.41%.
Earnings released on 23 Feb 2023
EPS came in at -$0.49 surpassing the estimated -$0.58 by +15.52%.
Earnings released on 3 Nov 2022
EPS came in at -$0.53 surpassing the estimated -$0.57 by +7.02%.
Earnings released on 3 Aug 2022
EPS came in at -$0.52 matching the estimated -$0.52.
Earnings released on 4 May 2022
EPS came in at -$0.49 surpassing the estimated -$0.52 by +5.77%.
Earnings released on 24 Feb 2022
EPS came in at -$0.49 surpassing the estimated -$0.54 by +9.26%.
Earnings released on 4 Nov 2021
EPS came in at -$0.50 surpassing the estimated -$0.54 by +7.41%.
Earnings released on 5 Aug 2021
EPS came in at -$0.51 falling short of the estimated -$0.49 by -4.08%.
Earnings released on 6 May 2021
EPS came in at -$0.46 falling short of the estimated -$0.42 by -9.52%.
Earnings released on 24 Feb 2021
EPS came in at -$0.45 matching the estimated -$0.45.
Earnings released on 5 Nov 2020
EPS came in at -$0.42 falling short of the estimated -$0.39 by -7.69%.
KURA Stock Performance
Access detailed KURA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.